CDXS
CDXS
NASDAQ · Life Sciences Tools & Services

Codexis Inc

$1.36
+0.04 (+3.03%)
Financial Highlights (FY 2026)
Revenue
91.80M
Net Income
-57,349,663
Gross Margin
86.7%
Profit Margin
-62.5%
Rev Growth
-20.2%
D/E Ratio
0.79
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 86.7% 86.7% 54.9% 54.9%
Operating Margin -59.3% -53.4% 15.1% 14.1%
Profit Margin -62.5% -59.4% 11.9% 9.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 91.80M 115.06M 48.43M 53.29M
Gross Profit 79.62M 99.80M 26.58M 29.25M
Operating Income -54,436,275 -61,409,686 7.30M 7.53M
Net Income -57,349,663 -64,696,285 5.77M 5.06M
Gross Margin 86.7% 86.7% 54.9% 54.9%
Operating Margin -59.3% -53.4% 15.1% 14.1%
Profit Margin -62.5% -59.4% 11.9% 9.5%
Rev Growth -20.2% -20.2% +4.8% -3.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 33.19M 33.19M 36.68M 34.44M
Total Equity 41.82M 41.82M 50.40M 46.39M
D/E Ratio 0.79 0.79 0.73 0.74
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -47,791,385 -56,908,768 7.56M 9.74M
Free Cash Flow — — 6.31M 7.69M